Bipolar Disorder treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2023 To 2030

-


The global Bipolar Disorder Treatment Market is estimated to be valued at US$ 8,732.9 Mn in 2023 and is expected to exhibit a CAGR of 5.4% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights. 

Market Overview:

Bipolar disorder, also known as manic-depressive illness, is a brain disorder that causes unusual shifts in mood, energy, activity levels, and the ability to carry out day-to-day tasks. The core symptoms involve periods of depression alternating with periods of elation or mania. Treatment aim to relieve symptoms and improve functioning. Medicines, psychological treatments and therapies help patients manage mood swings. 

Market key trends:

One of the key trends in bipolar disorder treatment market is rising demand for alternative therapies such as nutritional supplements, meditation, yoga and counseling. Many people with bipolar disorder are increasingly opting for combination of alternative therapies and prescription medicines to better manage their condition with less side effects. Cognitive behavioral therapy and dialectical behavior therapy are also gaining popularity as they teach interpersonal skills and coping mechanisms. Further, development of novel treatment approaches such as personalized treatments based on genetics, epigenetics and neural circuits promise hope for more effective and targeted therapies.

Read More Insights: https://www.coherentmarketinsights.com/market-insight/bipolar-disorders-treatment-market-2605

Segment Analysis

The global bipolar disorder treatment market is dominated by mood stabilizers segment, accounting for over 35% market share. Mood stabilizers such as lithium, valproate, and carbamazepine are effective in controlling acute manic and hypomanic episodes associated with bipolar disorder. Their efficacy and wide availability as generics have made them the preferred choice for long-term treatment of bipolar disorder. 

Key Takeaways

The global bipolar disorder treatment market is expected to witness high growth, exhibiting CAGR of 5.4% over the forecast period, due to increasing prevalence of bipolar disorder worldwide. 

Regional analysis

North America currently dominates the global bipolar disorder treatment market, owing to rising awareness about mental health and availability of advanced treatment options in the region. Asia Pacific is expected to witness fastest growth during the forecast period, due to growing healthcare expenditure and increasing adoption of novel drugs in countries like China and India.

Key players

Key players operating in the bipolar disorder treatment market are Takeda Pharmaceutical Company Limited, Pfizer, Inc., Allergan plc, Otsuka Holdings Co. Ltd., Johnson & Johnson, Eli Lilly and Company, GlaxoSmithKline plc, AstraZeneca Plc, Novartis International AG, AbbVie Inc., H. Lundbeck A/S, Minerva Neurosciences, Sumitomo Dainippon Pharma Co., Ltd., Intra-Cellular Therapies Inc., Gedeon Richter Plc., and Indivior PLC.

Comments

Post a Comment

Popular posts from this blog

Radiopharmaceuticals in Nuclear Medicine Market to Surpass US$ 11,504.8 Million by 2027

-
Image
There are numerous radiopharmaceuticals available for both therapeutic and diagnostic purposes, each with distinct and overlapping indications for specific disorders like Alzheimer's (Vizamyl, Amyvid, and Neuraceq). There are around 50 radiopharmaceuticals with U.S. FDA approval available for both therapeutic and diagnostic uses, with Technetium alone having over 30 approved compounds. Business Dynamics In order to increase their market presence, industry players are focusing on a variety of inorganic growth tactics including partnership and cooperation agreements, which is anticipated to accelerate the growth of the worldwide radiopharmaceuticals in nuclear medicine market over the forecast period. For instance, a distribution contract was signed by Cardinal Health Inc. and Telix Pharmaceuticals Inc., a division of Telix Pharmaceuticals Limited, in October 2018. In accordance with the contract, Cardinal Health will provide the 69Ga-PSMA Kit as well as create unit dosages of 68Ga-...
Read more

Breast Pumps Market to Surpass US$ 1,211.6 Million with a CAGR of 4.6% by 2027

-
Image
A breast pump is a mechanical tool used by breastfeeding women to suction-extract their breast milk, which they then use to feed their newborn children. Both manually and electrically driven breast pumping equipment is available. Breast pumps are advantageous for working women, women with shorter gestational periods, and women who give birth to multiples since they are unable to simultaneously breastfeed all of the babies, therefore they prefer a breast pump. Breast pumps aid in meeting the nutritional needs of babies of working mothers who do not want to sacrifice their development and growth since they are not constantly present with their infants. Business Dynamics Launches of breast pumps by leading industry players are anticipated to fuel the market's expansion throughout the forecast period. For instance, Sonata, the first smart breast pump to give hospital-level performance in a personal use breast pump, was introduced by Madela, Inc. in November 2016. This breast pump conn...
Read more

Angioedema Treatment Market Size, Trends, Industry Analysis, Overview, Share And Forecast 2024 To 2031

-
Image
Introduction: Angioedema, a condition characterized by rapid swelling of deeper layers of the skin and mucous membranes, poses a significant health concern for affected individuals. The Angioedema Treatment Market has been witnessing notable advancements, providing a ray of hope for patients grappling with this often unpredictable and potentially life-threatening condition. Market Dynamics: The Angioedema Treatment Market has experienced a paradigm shift in recent years, driven by increased awareness, improved diagnostic capabilities, and a surge in research and development efforts. Angioedema can be hereditary or acquired, and the market is witnessing a growing prevalence of both forms, necessitating a diversified approach to treatment options. Treatment Modalities: Therapeutic approaches to Angioedema have evolved, offering a range of options for patients. Antihistamines and corticosteroids are commonly prescribed for acute cases, providing relief from swelling and discomfort. In mor...
Read more